At ETPharma’s Biotech Symposium, Dr. Annu Uppal, USP India explained why India’s shift from scale-led manufacturing toward innovation-led biotech leadership must rest on investment, standards & execution in biologics & advanced therapies. Read article: https://t.co/sc9fxdosS0
At the 73rd @IPC in Hyderabad, experts discussed the evolving landscape of excipient standards driven by technology and global harmonization. Karthik Iyer highlighted USP's role in ensuring medication quality. Read more at: https://t.co/XsQdHEN0Il.
Visit: https://t.co/UOF7i4sIaL
.@USPharmacopeia is thrilled to announce the promotion of Girish Kapur to SVP of @USPinIndia Site Operations. #Like to join us in congratulating Girish on this well-deserved accomplishment and head to our newsroom for more: https://t.co/s5YCavNYlR
#ICYMI: USP senior leader @AnthonyLakavage recently shared his insights on our collaborative efforts to advance the supply of quality medicines manufactured in India and and beyond. Read more in our Quality Matters blog: https://t.co/rG8NpDKH24. ⤵️
"My visit to India allowed me to engage with leaders committed to advancing the supply of quality medicines in India and worldwide." 💬 USP SVP @AnthonyLakavage
Watch 🎥 ⤵️ and read: https://t.co/Dv3KfvLgFF for more from Tony on our latest collaborative efforts in India.
#ICYMI: Recently, @CDSCO_INDIA_INF's Dr. Rajeev Raghuvanshi, @US_FDA's Dr. Sarah McMullen, #USP leaders, and more united to discuss advancing quality, accessible medicine at our 4th South Asia Regional Chapter Meeting. See highlights from this vital exchange on #PublicHealth. ⤵️
(6/7) Building supply chain resilience and enabling global stakeholders to reduce the proliferation of poor-quality antimicrobial medicines are among the multi-faceted approaches needed to address #antimicrobialresistance. More here: https://t.co/dFQRjFmztX #WAAW22
(5/7) USP’s Quality Institute fellows researched the different ways that poor quality can contribute to #AMR, including subtherapeutic doses of the active pharmaceutical ingredient, poor quality inactive ingredients, or the presence of impurities https://t.co/xTlEWqm8ZO #WAAW22
(4/7) While the issue of substandard & falsified medicines is most acutely experienced in low-income and middle-income settings, the consequences affect the quality and effectiveness of #antimicrobials worldwide #WAAW22
Increased visibility into the #medicines#SupplyChain through USP’s Medicine Supply Map can help identify and address vulnerabilities, reduce the frequency and duration of potential drug shortages, and help protect patients. Learn more. https://t.co/kycwLAFl91
USP salutes the nation on its 75th Independence Day! The day is celebrated to honour the struggle of India's freedom fighters who went through countless sufferings to attain independence. USP India staff celebrated by hoisting the Indian National flag. #USPIndia
USP kicks off the new FY in style! USP South Asia RPO team had a power-packed three days celebration, where the team reflected on the previous year’s performance and the goals and focus areas for the current year, followed by some fun team-building activities.
#USPIndia celebrated “Cultural #Diversity Day” on 28 June 2022. USP staff set up stalls to show the diverse culture of various parts of India and participated in different team activities. It was a fun-filled day with team-building activities, cultural food, music and dance.